Note: Ingredients listed on restricted chemical lists
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.1
EC/CAS
270-115-0/68411-30-3
Name of the chemical
Benzenesulfonic acid,C10-13-alkyl derivs., sodium salts
Concentration
1-3
General Information
Product name
SABRE
Emergency telephone
Comment
Icons in SDS
Company Information
company name
SELDEN RESEARCH LIMITED
e-mail address of the competent person responsible for the Safety Data Sheet
sds@selden.eu, safety@selden.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
CLP CLASSIFICATION
Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
Causes serious eye irritation.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard pictograms
08/02/2023 (Revision date) Document generated @ 08/02/2023 14 59 49 EN (English) Page 1 of 9 GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P264 - Wash hands thoroughly after handling. P280 - Wear eye protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention.
Supplemental label elements
EUH208 - Contains reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl- 2H-isothiazol-3-one (3:1). May produce an allergic reaction.
2.3 Other hazards
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %